Beyond Glycemic Control: How Early Should Diabetic Eye Disease Be Treated?

Beyond Glycemic Control: How Early Should Diabetic Eye Disease Be Treated? is organized by Medscape, LLC.

CME / ABIM MOC / CE Released: 12/21/2020
Valid for credit through: 12/21/2021

Accreditation:
For Physicians
Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit Statement: 
This course is COPE approved for 0.25 hours of CE credit. Activity #120793 and Course ID 70548-SD. Check with your local state licensing board to see if this counts toward your CE requirement for re-licensure.

Goal Statement:
The goal of this activity is to help primary care physicians and optometrists identify patients at risk of diabetic retinopathy (DR) and emphasize the need for referral, stressing the importance that eye exams happen to enable early intervention to prevent vision loss. The latest data from American Academy of Ophthalmology (AAO) 2020 virtual meeting will be included.

Learning Objectives:
Upon completion of this activity, participants will:
• Have increased knowledge regarding the
? Management strategies for nonproliferative diabetic retinopathy (NPDR)
• Have greater competence related to
? Identifying patients at risk of diabetic eye disease